Latest & greatest articles for measles

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on measles or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on measles and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for measles

81. WITHDRAWN: Antibiotics for preventing pneumonia in children with measles. (Abstract)

WITHDRAWN: Antibiotics for preventing pneumonia in children with measles. Measles causes more than a million deaths a year, of which most are children under five years of age who die from pneumonia.The objective of this review was to assess the effects of antibiotics given to children with measles on reducing pneumonia or mortality, and to assess whether antibiotics should be given to all children with measles in communities with a high fatality rate.We searched MEDLINE (1966 - 1999), EMBASE (...) with measles. Available evidence suggests that antibiotics should be given only if a child has clinical signs of pneumonia or other evidence of sepsis.

2007 Cochrane

82. Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. (Abstract)

Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. In 2002, the UN General Assembly Special Session on Children adopted a goal to reduce deaths owing to measles by half by the end of 2005, compared with 1999 estimates. We describe efforts and progress made towards this goal.We assessed trends in immunisation against measles on the basis of national implementation of the WHO/UNICEF comprehensive strategy for measles mortality reduction (...) , and the provision of a second opportunity for measles immunisation. We used a natural history model to evaluate trends in mortality due to measles.Between 1999 and 2005, according to our model mortality owing to measles was reduced by 60%, from an estimated 873,000 deaths (uncertainty bounds 634,000-1,140,000) in 1999 to 345,000 deaths (247,000-458,000) in 2005. The largest percentage reduction in estimated measles mortality during this period was in the western Pacific region (81%), followed by Africa (75

2007 Lancet

83. Susceptibility to measles, mumps, and rubella in newly arrived adult immigrants and refugees. (Abstract)

Susceptibility to measles, mumps, and rubella in newly arrived adult immigrants and refugees. Despite effective vaccination programs for measles, mumps, and rubella in the United States and Canada, outbreaks continue to occur in susceptible subgroups, such as foreign-born persons.To determine the susceptibility of newly arrived immigrants and refugees to measles, mumps, and rubella.Seroprevalence study.Two hospitals and three community clinics in Montreal, Quebec, Canada.1480 adult immigrants (...) and refugees who were recruited from October 2002 to December 2004.Sociodemographic and clinical data and serology for measles, mumps, and rubella.Thirty-six percent (range, 22% to 54%) of the study population was nonimmune to at least 1 of the 3 diseases. This proportion varied by age, sex, and region of origin. In multivariate analysis and after adjustment for region of origin, age, and socioeconomic factors, immigrant women had higher odds (odds ratio, 2.1) of being immune to measles (95% CI, 1.2 to 3.8

2007 Annals of Internal Medicine

84. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. (Abstract)

Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. Measles was declared eliminated from the United States in 2000 but remains endemic worldwide. In 2005, a 17-year-old unvaccinated girl who was incubating measles returned from Romania, creating the largest documented outbreak of measles in the United States since 1996.We conducted a case-series investigation, molecular typing of viral isolates, surveys of rates of vaccination coverage (...) , interviews regarding attitudes toward vaccination, and cost surveys.Approximately 500 persons attended a gathering with the index patient one day after her return home. Approximately 50 lacked evidence of measles immunity, of whom 16 (32 percent) acquired measles at the gathering. During the six weeks after the gathering, a total of 34 cases of measles were confirmed. Of the patients with confirmed measles, 94 percent were unvaccinated, 88 percent were less than 20 years of age, and 9 percent were

2006 NEJM

85. Chinese medicinal herbs for measles. (Abstract)

Chinese medicinal herbs for measles. Measles is an infectious disease caused by Morbillivirus. Chinese physicians believe that medicinal herbs are effective in alleviating symptoms and preventing complications. Chinese herbal medicines are dispensed according to the particular symptoms.To assess the effectiveness and possible adverse events of Chinese medicinal herbs in treating measles.We searched the Cochrane Central Register of Controlled Clinical Trials (CENTRAL) (The Cochrane Library Issue (...) 4, 2005); MEDLINE (1966 to June 2005); EMBASE (1980 to June 2005); the Chinese Biomedical Database (1976 to June 2005); VIP Information (1989 to June 2005); China National Knowledge Infrastructure (CNKI) (1994 to June 2005); and the metaRegister of Controlled Trials was searched for ongoing trials.Randomised controlled trials (RCTs) in which patients with measles without complications were treated with Chinese medicinal herbs were included.The primary outcome measure was death from any cause

2006 Cochrane

86. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?

Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective? Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective? Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective? Celikbas A, Ergonul O, Aksaray S, Tuygun N, Esener H, Tanir G, Eren S, Baykam N, Guvener E (...) , Dokuzoguz B Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study investigated the use of a programme for screening health care workers for their immunity to measles, rubella, mumps and varicella (MMRV), with those with no immunity

2006 NHS Economic Evaluation Database.

87. Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau. (Full text)

Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau. To investigate whether prophylactic antibiotics can prevent complications of measles.Community based, randomised, double blind, placebo controlled trial.Bandim Health Project study area in Bissau, Guinea-Bissau, west Africa.84 patients with measles during a measles epidemic in Bissau in 1998 (fewer than originally planned owing (...) to interruption by war).Sulfamethoxazole-trimethoprim (co-trimoxazole) or placebo for seven days.Pneumonia and admission to hospital. Also weight change during the first month of infection, diarrhoea, severe fever, oral thrush, stomatitis, conjunctivitis, and otitis media.The median age of the patients with measles was 5.4 (range 0.49-24.8) years. One of 46 participants who received co-trimoxazole developed pneumonia, in contrast to six of 38 participants who received placebo (odds ratio 0.08 (95% confidence

2006 BMJ Controlled trial quality: predicted high PubMed abstract

88. Public-health impact of accelerated measles control in the WHO African Region 2000-03. (Full text)

Public-health impact of accelerated measles control in the WHO African Region 2000-03. In 2000, the WHO African Region adopted a plan to accelerate efforts to lower measles mortality with the goal of decreasing the number of measles deaths to near zero. By June, 2003, 19 African countries had completed measles supplemental immunisation activities (SIA) in children aged 9 months to 14 years as part of a comprehensive measles-control strategy. We assessed the public-health impact of these control (...) measures by use of available surveillance data.We calculated percentage decline in reported measles cases during 1-2 years after SIA, compared with 6 years before SIA. On the basis of data from 13 of the 19 countries, we assumed that the percentage decline in measles deaths equalled that in measles cases. We also examined data on routine and SIA measles vaccine coverage, measles case-based surveillance, and suspected measles outbreaks.Between 2000 and June, 2003, 82.1 million children were targeted

2005 Lancet PubMed abstract

89. Review: existing epidemiological evidence does not show an association between mumps, measles, and rubella vaccination and autism (Full text)

Review: existing epidemiological evidence does not show an association between mumps, measles, and rubella vaccination and autism Review: existing epidemiological evidence does not show an association between mumps, measles, and rubella vaccination and autism | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: existing epidemiological evidence does not show an association between mumps, measles, and rubella vaccination and autism Article

2005 Evidence-Based Nursing PubMed abstract

90. Measles, mumps, and rubella vaccine was not associated with autism in children (Full text)

Measles, mumps, and rubella vaccine was not associated with autism in children Measles, mumps, and rubella vaccine was not associated with autism in children | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Measles, mumps, and rubella vaccine was not associated with autism in children Article Text Causation Measles, mumps, and rubella vaccine was not associated with autism in children Free Stephanie Wright , CFNP, CPNP, PhD Statistics from

2004 Evidence-Based Nursing PubMed abstract

91. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States (Full text)

An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States Zhou F J, Reef S, Massoudi M, Papania M J, Yusuf H R, Bardenheier B, Zimmerman L, McCauley M M Record Status This is a critical abstract of an economic (...) evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology A two-dose measles-mumps-rubella (MMR) vaccination programme was compared with no vaccination and with a one-dose MMR vaccination scheme. Type of intervention Primary prevention. Economic study type Cost-effectiveness analysis and cost-benefit

2004 NHS Economic Evaluation Database. PubMed abstract

92. Cost-effectiveness of three different vaccination strategies against measles in Zambian children

Cost-effectiveness of three different vaccination strategies against measles in Zambian children Cost-effectiveness of three different vaccination strategies against measles in Zambian children Cost-effectiveness of three different vaccination strategies against measles in Zambian children Dayan G H, Cairns L, Sangrujee N, Mtonga A, Nguyen V, Strebel P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains (...) a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Three vaccination strategies against measles were examined. In the first (strategy 1), one dose of measles vaccine was delivered through the routine health care system at 9 months of age. In the second (strategy 2), one dose of measles vaccine was delivered through the routine health care system at 9 months of age

2004 NHS Economic Evaluation Database.

93. Measles: not just another viral exanthem. (Abstract)

Measles: not just another viral exanthem. Measles is the most frequent cause of vaccine-preventable childhood deaths. Infants younger than the recommended age for vaccination are susceptible to the disease, and in developing countries they have a high risk of complications and mortality. Vaccine coverage in excess of 95% interrupts endemic transmission of measles in many countries, but achievement of such coverage almost always requires coordinated supplementary mass vaccination campaigns (...) . There are substantial health gains if countries improve measles vaccine coverage, irrespective of whether or not high coverage is achieved; these gains include much lower measles complication and case fatality rates, long-term interepidemic duration, and possibly non-specific improvements in survival of children. Investigation into the cost-effectiveness of different strategies for measles control, including mass campaigns, two-dose schedules, and young-infant doses, would help countries to formulate control

2003 Lancet

94. Association of autistic spectrum disorder and the measles, mumps, and rubella vaccine: a systematic review of current epidemiological evidence

Association of autistic spectrum disorder and the measles, mumps, and rubella vaccine: a systematic review of current epidemiological evidence Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2003 DARE.

95. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies. (Abstract)

Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies. Females given high-titre measles vaccine (HTMV) have high mortality; diphtheria-tetanus-pertussis (DTP) vaccination might be associated with increased female mortality. We aimed to assess whether DTP or inactivated poliovirus (IPV) administered after HTMV was associated with increased (...) female-male mortality ratio.In three trials from West Africa, 2000 children were randomised to HTMV or control vaccine at 4-5 months of age; a second vaccination was given at age 9-10 months (standard measles vaccine). Children in high-titre groups were given IPV or DTP-IPV. Another 944 children received HTMV as routine vaccination in Senegal.When we compared high-titre and control groups, no difference in mortality between the first and the second vaccination was noted. After the second vaccination

2003 Lancet Controlled trial quality: uncertain

96. The measles-mumps-rubella vaccine (MMR) and autism

The measles-mumps-rubella vaccine (MMR) and autism The measles-mumps-rubella vaccine (MMR) and autism The measles-mumps-rubella vaccine (MMR) and autism Higgins S Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Higgins S. The measles-mumps-rubella vaccine (MMR) and autism. Clayton, Victoria: Centre for Clinical Effectiveness (CCE) 2003: 14 Authors' objectives (...) This aim of this critical appraisal was to assess whether the combined measles-mumps-rubella vaccine (MMR) given according to the Department of Health's immunisation schedule increase the child's risk of developing autism. Project page URL Indexing Status Subject indexing assigned by CRD MeSH Autistic Disorder; Measles-Mumps-Rubella Vaccine /adverse effects Language Published English Country of organisation Australia Address for correspondence Monash Institute of Health Services Research, Block E

2003 Health Technology Assessment (HTA) Database.

97. A population-based study of measles, mumps, and rubella vaccination and autism. (Abstract)

A population-based study of measles, mumps, and rubella vaccination and autism. It has been suggested that vaccination against measles, mumps, and rubella (MMR) is a cause of autism.We conducted a retrospective cohort study of all children born in Denmark from January 1991 through December 1998. The cohort was selected on the basis of data from the Danish Civil Registration System, which assigns a unique identification number to every live-born infant and new resident in Denmark. MMR

2002 NEJM

98. First 5 years of measles elimination in southern Africa: 1996-2000. (Abstract)

First 5 years of measles elimination in southern Africa: 1996-2000. Measles is the leading cause of vaccine-preventable death in Africa. Regional measles elimination is considered feasible using current vaccines and a series of WHO-recommended strategies. We aimed to interrupt transmission of measles, and to use case-based surveillance to show the effect of such interruption.In southern Africa from 1996, seven countries with a total population of approximately 70 million and with relatively (...) high routine vaccination coverage implemented measles elimination strategies. In addition to routine measles immunisation at 9 months of age, these included nationwide catch-up campaigns among children aged 9 months to 14 years, then follow-up campaigns every 3-4 years among children aged 9-59 months, and the establishment of case-based measles surveillance with serological diagnostic confirmation.Nearly 24 million children aged 9 months to 14 years were vaccinated, with overall vaccination

2002 Lancet

99. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. (Full text)

Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. To investigate whether measles, mumps, and rubella (MMR) vaccination is associated with bowel problems and developmental regression in children with autism, looking for evidence of a "new variant" form of autism.Population study with case note review linked to independently recorded vaccine data.Five health districts in north east London.278 children with core autism

2002 BMJ PubMed abstract

100. Effect of vitamin A supplementation on measles-specific antibody levels in Guinea-Bissau. (Abstract)

Effect of vitamin A supplementation on measles-specific antibody levels in Guinea-Bissau. We have previously reported that vitamin A supplementation with measles vaccine at age 9 months increases measles-specific antibody concentrations in children at age 18 months compared with placebo. We examined these children when they reached age 6-8 years. Fewer vitamin A-supplemented children had non-protective antibody concentrations (p=0.0095); among children with protective antibody levels, vitamin (...) A-supplemented children tended to have higher geometric mean antibody titres (p=0.09). Thus, simultaneous administration of vitamin A and measles vaccine at age 9 months had a long-term effect on measles-specific antibody levels and may contribute to improved measles control in less-developed countries.

2002 Lancet Controlled trial quality: uncertain